Literature DB >> 18396272

Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Aamir R Zuberi1, Leigh Townsend, Laurel Patterson, Huiyuan Zheng, Hans-Rudi Berthoud.   

Abstract

The mu-opioid receptor encoded by the Oprm1 gene plays a crucial role in the mediation of food reward and drug-induced positive reinforcement, but its genetic deletion has been shown to provide food intake-independent, partial protection from diet-induced obesity. We hypothesized that mu-opioid receptor-deficient mice would show an even greater, intake-dependent, resistance to high-fat diet-induced obesity if the diet comprises a sweet component. We generated an F2 population by crossing the heterozygous offspring of homozygous female Oprm1(-/-) mice (on a mixed C57BL/6 and BALB/c genetic background) with male inbred C57BL/6 mice. Groups of genotyped wild-type (WT) and homozygous mutant (KO) males and females were fed either control chow or a high caloric palatable diet consisting of sweet, liquid chocolate-flavored Ensure together with a solid high-fat diet. Food intake, body weight, and body composition was measured over a period of 16 weeks. Unexpectedly, male, and to a lesser extent female, KO mice fed chow for the entire period showed progressively increased body weight and adiposity while eating significantly more chow. In contrast, when exposed to the sweet plus high-fat diet, male, and to a lesser extent female, KO mice gained significantly less body weight and fat mass compared to WT mice when using chow fed counterparts for reference values. Male KO mice consumed 33% less of the sweet liquid diet but increased intake of high-fat pellets, so that total calorie intake was not different from WT animals. These results demonstrate a dissociation of the role of mu-opioid receptors in the control of adiposity for different diets and sex. On a bland diet, normal receptor function appears to confer a slightly catabolic predisposition, but on a highly palatable diet, it confers an anabolic metabolic profile, favoring fat accretion. Because of the complexity of mu-opioid gene regulation and tissue distribution, more selective and targeted approaches will be necessary to fully understand the underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396272      PMCID: PMC2430069          DOI: 10.1016/j.ejphar.2008.01.047

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  45 in total

1.  Rapid induction of insulin resistance in opioid mu-receptor knock-out mice.

Authors:  Juei-Tang Cheng; I-Min Liu; Chih Fen Hsu
Journal:  Neurosci Lett       Date:  2003-03-20       Impact factor: 3.046

Review 2.  Opioid peptides and the control of human ingestive behaviour.

Authors:  Martin R Yeomans; Richard W Gray
Journal:  Neurosci Biobehav Rev       Date:  2002-10       Impact factor: 8.989

Review 3.  Opioid modulation of taste hedonics within the ventral striatum.

Authors:  A E Kelley; V P Bakshi; S N Haber; T L Steininger; M J Will; M Zhang
Journal:  Physiol Behav       Date:  2002-07

4.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

5.  Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population.

Authors:  Carla J Gallagher; Candace J Gordon; Carl D Langefeld; Josyf C Mychaleckyj; Barry I Freedman; Stephen S Rich; Donald W Bowden; Michèle M Sale
Journal:  Mol Genet Metab       Date:  2005-09-02       Impact factor: 4.797

6.  Portion size of food affects energy intake in normal-weight and overweight men and women.

Authors:  Barbara J Rolls; Erin L Morris; Liane S Roe
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

7.  micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.

Authors:  Dania Chakass; David Philippe; Edmone Erdual; Sébastien Dharancy; Mathilde Malapel; Caroline Dubuquoy; Xavier Thuru; Jerome Gay; Claire Gaveriaux-Ruff; Pierre Dubus; Philippe Mathurin; Brigitte L Kieffer; Pierre Desreumaux; Mathias Chamaillard
Journal:  Gut       Date:  2007-02-13       Impact factor: 23.059

8.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

Authors:  I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

9.  Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence.

Authors:  Carlo Colantuoni; Pedro Rada; Joseph McCarthy; Caroline Patten; Nicole M Avena; Andrew Chadeayne; Bartley G Hoebel
Journal:  Obes Res       Date:  2002-06

Review 10.  Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology.

Authors:  George F Koob; Amanda J Roberts; Brigitte L Kieffer; Charles J Heyser; Simon N Katner; Roberto Ciccocioppo; Friedbert Weiss
Journal:  Recent Dev Alcohol       Date:  2003
View more
  14 in total

1.  Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Authors:  Traci A Czyzyk; Amparo Romero-Picó; John Pintar; Jaime H McKinzie; Matthias H Tschöp; Michael A Statnick; Ruben Nogueiras
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

Review 2.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

Review 3.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

4.  Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.

Authors:  A C Shin; P J Pistell; C B Phifer; H R Berthoud
Journal:  Neuroscience       Date:  2010-07-27       Impact factor: 3.590

5.  The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugs.

Authors:  Jean-Philippe Fortin; Lei Ci; Jonathan Schroeder; Carmit Goldstein; Maria Claudia Montefusco; Inga Peter; Steven E Reis; Gordon S Huggins; Martin Beinborn; Alan S Kopin
Journal:  Mol Pharmacol       Date:  2010-08-11       Impact factor: 4.436

6.  Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.

Authors:  N R Lenard; H Zheng; H-R Berthoud
Journal:  Int J Obes (Lond)       Date:  2010-01-12       Impact factor: 5.095

7.  Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.

Authors:  Kenneth Blum; John Bailey; Anthony M Gonzalez; Marlene Oscar-Berman; Yijun Liu; John Giordano; Eric Braverman; Mark Gold
Journal:  J Genet Syndr Gene Ther       Date:  2011-12-23

8.  Involvement of Endogenous Enkephalins and β-Endorphin in Feeding and Diet-Induced Obesity.

Authors:  Ian A Mendez; Sean B Ostlund; Nigel T Maidment; Niall P Murphy
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

9.  Mice lacking the G protein gamma3-subunit show resistance to opioids and diet induced obesity.

Authors:  William F Schwindinger; Brandon M Borrell; Lora C Waldman; Janet D Robishaw
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-16       Impact factor: 3.619

10.  kappa-Opioid receptors control the metabolic response to a high-energy diet in mice.

Authors:  Traci A Czyzyk; Ruben Nogueiras; John F Lockwood; Jamie H McKinzie; Tamer Coskun; John E Pintar; Craig Hammond; Matthias H Tschöp; Michael A Statnick
Journal:  FASEB J       Date:  2009-11-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.